Visionary Holdings

GV

Market cap $3.97M

Company Continues Expansion into North America and Europe as Part of Global Medical Aesthetics Strategy Company Continues Expansion into North America and Europe as Part of Global Medical Aesthetics Strategy

HONG KONG, March 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational and biotechnology and healthcare-focused company, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), today announced the signing of a US$12 million exclusive distribution agreement for its flagship anti-aging product, Premier Regenerative Complex---President Super Injection, in cooperation with Huajin China Investment Company（”Huajin China”), alongside the Board-approved divestiture of its non-core education business.

HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“the Company”), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited (“GV Hong Kong”), continued execution progress under its previously signed commercial sales agreement with a total contract value of approximately US$9 million. The agreement, signed in September 2025, is currently in the implementation stage, with service activities underway.

HONG KONG, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven multinational enterprise, today announced that its wholly owned subsidiary, Visionary Health Technology Group Limited, has established three new regional wholly owned subsidiaries in Qingdao, Wuxi and Wuhu, China.

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”) announced today that in December 2025 it entered into a securities purchase agreement with an existing institutional investor (the “Investor”). In connection with the transaction, the Company issued to the Investor a senior secured convertible promissory note in the principal amount of $500,000 (the “December 2025 Note”) in exchange for gross proceeds of $450,000.

MARKHAM, Ontario, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (Nasdaq: GV) (the “Company”), a high-growth technology company specializing in innovative software solutions for the aesthetic medicine industry and cutting-edge advancements in stem cell research, today announced that it has received two formal communications from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) relating to the Company's periodic reporting status.

TORONTO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Visionary Holdings Inc. (“GV” or the “Company”), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) in connection with the filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025. As previously disclosed, on August 5, 2025, the Company was notified by Nasdaq that it was not in compliance with the periodic filing requirement under Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Annual Report on Form 20-F for the fiscal year ended March 31, 2025.

TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "CORRECTION – Visionary Holdings Inc." on Tuesday, January 13th by Visionary Holdings Inc. (Nasdaq: GV), please be advised there was an error in the attached Form 20-F PDF. The corrected release with the corrected attachment follows:

TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "Visionary Holdings Inc. Reports Fiscal Year 2025 Annual Report" on Monday, January 12th by Visionary Holdings Inc. (Nasdaq: GV), please be advised that the headline and content have been updated to accurately reflect comments from the U.S. Securities and Exchange Commission. The corrected release follows: Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending  Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the public release of its final annual report and audited financial statements for the fiscal year ended March 31, 2025.

Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses